Logo image of CTCX

CARMELL CORP (CTCX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CTCX - US1429221039 - Common Stock

0.1973 USD
+0 (+1.39%)
Last: 3/7/2025, 8:16:34 PM
Fundamental Rating

0

Taking everything into account, CTCX scores 0 out of 10 in our fundamental rating. CTCX was compared to 525 industry peers in the Biotechnology industry. CTCX has a bad profitability rating. Also its financial health evaluation is rather negative. CTCX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CTCX has reported negative net income.
  • In the past year CTCX has reported a negative cash flow from operations.
CTCX Yearly Net Income VS EBIT VS OCF VS FCFCTCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

  • CTCX has a Return On Assets of -1047.34%. This is amonst the worse of the industry: CTCX underperforms 97.90% of its industry peers.
Industry RankSector Rank
ROA -1047.34%
ROE N/A
ROIC N/A
ROA(3y)-8.43%
ROA(5y)N/A
ROE(3y)-21.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTCX Yearly ROA, ROE, ROICCTCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CTCX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTCX Yearly Profit, Operating, Gross MarginsCTCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CTCX has more shares outstanding
  • CTCX has a worse debt/assets ratio than last year.
CTCX Yearly Shares OutstandingCTCX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
CTCX Yearly Total Debt VS Total AssetsCTCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -52.95, we must say that CTCX is in the distress zone and has some risk of bankruptcy.
  • CTCX has a Altman-Z score of -52.95. This is amonst the worse of the industry: CTCX underperforms 93.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -52.95
ROIC/WACCN/A
WACCN/A
CTCX Yearly LT Debt VS Equity VS FCFCTCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M

2.3 Liquidity

  • CTCX has a Current Ratio of 0.31. This is a bad value and indicates that CTCX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.31, CTCX is not doing good in the industry: 94.41% of the companies in the same industry are doing better.
  • CTCX has a Quick Ratio of 0.31. This is a bad value and indicates that CTCX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CTCX has a Quick ratio of 0.29. This is amonst the worse of the industry: CTCX underperforms 94.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.29
CTCX Yearly Current Assets VS Current LiabilitesCTCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

  • CTCX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -335.78%.
  • Looking at the last year, CTCX shows a very negative growth in Revenue. The Revenue has decreased by -99.12% in the last year.
EPS 1Y (TTM)-335.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.39%
Revenue 1Y (TTM)-99.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-99.45%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CTCX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTCX Price Earnings VS Forward Price EarningsCTCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTCX Per share dataCTCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CTCX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARMELL CORP / CTCX FAQ

What is the ChartMill fundamental rating of CARMELL CORP (CTCX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to CTCX.


What is the valuation status for CTCX stock?

ChartMill assigns a valuation rating of 0 / 10 to CARMELL CORP (CTCX). This can be considered as Overvalued.


How profitable is CARMELL CORP (CTCX) stock?

CARMELL CORP (CTCX) has a profitability rating of 0 / 10.


Can you provide the financial health for CTCX stock?

The financial health rating of CARMELL CORP (CTCX) is 0 / 10.